Brief: Hofseth Biocare Names Jon Olav Ødegård New CEO
July 29 (Reuters) - Hofseth Biocare ASA HBC.OL :
* JON OLAV ØDEGÅRD APPOINTED NEW CEO OF HBC
* ROGER HOFSETH WILL CONTINUE TO SERVE AS CEO OF HOFSETH INTERNATIONAL BUT HAS DECIDED TO
STEP
BACK AS CEO OF HBC
* JON OLAV ØDEGÅRD, CHIEF FINANCIAL OFFICER WILL, WITH EFFECT FROM 1 AUGUST, ASSUME ROLE OF
CEO
Source text for Eikon: ID:nGNE4M1lpr
Further company coverage: HBC.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering